Apollomics (APLM) Retained Earnings (2021 - 2025)
Apollomics (APLM) posted quarterly Retained Earnings of -$711.8 million for Q4 2025, down 12171.76% quarter-over-quarter from -$5.8 million in Q4 2023.
Apollomics (APLM) Retained Earnings (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Retained Earnings for 4 consecutive years, with -$711.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings changed N/A year-over-year to -$711.8 million; the TTM figure through Dec 2025 stood at -$711.8 million (changed N/A YoY), while the FY2025 annual figure was -$711.8 million, changed N/A from the prior year.
- Retained Earnings fell to -$711.8 million in Q4 2025 per APLM's latest filing, from -$5.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $19.3 million in Q2 2023 and bottomed at -$711.8 million in Q4 2025.
- Historically, Retained Earnings has averaged -$153.2 million across 4 years, with a median of -$2.9 million in 2022.
- On a YoY basis, Retained Earnings climbed as much as 39694.76% in 2023 and fell as far as 140.76% in 2023.
- Apollomics' Retained Earnings stood at -$235.4 million in 2021, then soared by 106.04% to $14.2 million in 2022, then tumbled by 140.76% to -$5.8 million in 2023, then tumbled by 12171.76% to -$711.8 million in 2025.
- Business Quant data shows APLM's Retained Earnings at -$711.8 million in Q4 2025, -$5.8 million in Q4 2023, and $19.3 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | Apollomics | 34.08 Mn | 30.81 Mn | - | -711.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -711.76 Mn |
| Dec 31, 2023 | -5.80 Mn |
| Jun 30, 2023 | 19.31 Mn |
| Dec 31, 2022 | 14.23 Mn |
| Jun 30, 2022 | 48,529.00 |
| Dec 31, 2021 | -235.44 Mn |